The EHA Research Roadmap: Malignant Lymphoid Diseases

• Authors: DREYLING Martin; ANDRE Marc; GOKBUGET Nicola; TILLY Herve; JERKEMAN Mats; GRIBBEN John; FERRERI Andres; MOREL Pierre; STILGENBAUER Stephan; FOX Christopher; JOSE Maria Ribera; ZWEEGMAN Sonja; AURER Igor; BODOR Csaba; BURKHARDT Birgit; BUSKE Christian; MARIA Dollores Caballero; CAMPO Elias; CHAPUY Bjoern; DAVIES Andrew; LAURENCE de Leval; DOORDUIJN Jeanette; FEDERICO Massimo; GAULARD Philippe; GAY Francesca; GHIA Paolo; GRONBAEK Kirsten; GOLDSCHMIDT Hartmut; KERSTEN Marie-Jose; KIESEWETTER Barbara; LANDMAN-PARKER Judith; STEVEN Le Gouill; LENZ Georg; LEPPA Sirpa; LOPEZ-GUILLERMO Armando; MACINTYRE Elizabeth; MANTEGA Maria Victoria Mateos; MOREAU Philippe; MORENO Carol; NADEL Bertrand; OKOSUN Jessica; OWEN Roger; POSPÍŠILOVÁ Šárka; POTT Christiane; ROBAK Tadeusz; SPINA Michelle; STAMATOPOULOS Kostas; STARY Jan; TARTE Karin; TEDESCHI Allessandra; THIEBLEMONT Catherine; TRAPPE Ralf Ulrich; TRUMPER Lorenz H; SALLES Gilles
• Year of publication: 2022
• Type: Article in Periodical
• Magazine / Source: HemaSphere
• MU Faculty or unit: Faculty of Medicine
• Web: https://journals.lww.com/hemasphere/Fulltext/2022/06000/The_EHA_Research_Roadmap__Malignant_Lymphoid.10.aspx
• Doi: http://dx.doi.org/10.1097/HS9.0000000000000726
• Keywords: Malignant Lymphoid Diseases; EHA Research Roadmap
• Description: In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research aiming to highlight achievements in the diagnostics and treatment of blood disorders and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.